NCT05299970 (LAFIABAGA) is a NA clinical trial of Fermented porridge in Inflammation, sponsored by Institut de Recherche en Sciences de la Sante, Burkina Faso.

Who is sponsoring NCT05299970?

NCT05299970 is sponsored by Institut de Recherche en Sciences de la Sante, Burkina Faso.

What drugs are being tested in NCT05299970?

Interventions in NCT05299970: Fermented porridge.

What condition does NCT05299970 study?

NCT05299970 studies Inflammation, Microbiome, Human.

Is NCT05299970 still recruiting?

NCT05299970 is currently status unknown. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT05299970: LAFIABAGA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women

Status unknown NA Last updated 23 October 2023

What this trial tests

NA trial testing Fermented porridge in Inflammation in 80 participants. Status unknown.

Timeline

21 March 2022

Primary endpoint
30 January 2024

31 July 2024

Quick facts

Lead sponsor	Institut de Recherche en Sciences de la Sante, Burkina Faso
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	80
Start date	21 March 2022
Primary completion	30 January 2024
Estimated completion	31 July 2024
Sites	1 location across Burkina Faso

Drugs / interventions tested

Fermented porridge

Conditions studied

Inflammation — all drugs for Inflammation →
Microbiome, Human — all drugs for Microbiome, Human →

Sponsor

Institut de Recherche en Sciences de la Sante, Burkina Faso — full company profile →

Who can join

Adults 18 to 49, female only, with Inflammation or Microbiome, Human. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Maternal undernutrition concerns 10-19% of women of reproductive age globally, the vast majority of which live in sub Saharan Africa and south Asia. Recommendations for nutritional interventions to tackle the problem range from per-pregnancy supplementation to upstream interventions targeting women of reproductive age before conception. To render the latter interventions cost-effective and sustainable, experts recommend to focus on food processing that leads to an enhanced nutrient content. One such method, which has been known and practiced for centuries in diverse societies, is fermentation. Traditionally fermented foods are diverse, widespread and highly appreciated in Burkina Faso. The present study aims to investigate the effect of fermented millet porridge on gut microbiota diversity, stool short chain fatty acid concentration and inflammation markers level in women of reproductive age living in rural Burkina Faso.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.
Asaf S, Maqsood F, Jalil J, Sarfraz Z, et al · · 2023 · cited 38× · PMID 36529828 · DOI 10.1007/s12026-022-09352-2

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07269847 — Comparing a Healthy Beef-Centric Diet to a Healthy U.S.-Style Diet on Metabolic Health Outcomes in Pre-Diabetic Adults · NA · recruiting
NCT07171450 — Cognitive Remediation · NA · recruiting
NCT07411612 — The Association Between Postoperative Inflammatory and Neurological Serum Biomarker Concentrations and Occurrence of Pos · recruiting

Other Institut de Recherche en Sciences de la Sante, Burkina Faso trials

Trials by the same sponsor.

NCT06759493 — Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe Schoolchildren · recruiting
NCT05285657 — Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases. · NA · completed
NCT04816461 — Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates · Phase 4 · completed
NCT04147546 — Additional Screening With Sensitives RDTs and Malaria · Phase 3 · completed
NCT03156751 — Feasibility of Introducing an Onsite Test for Syphilis in the Package of Antenatal Care in Burkina Faso · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05299970 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut de Recherche en Sciences de la Sante, Burkina Faso
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05299970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing